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Abstract
Survival models are a popular tool for the analysis of time to event data with applica-
tions in medicine, engineering, economics and many more. Advances like the Cox
proportional hazard model have enabled researchers to better describe hazard rates
for the occurrence of single fatal events, but are limited by modeling assumptions,
like proportionality of hazard rates and linear effects. Moreover, common phenom-
ena are often better described through multiple states, for example, the progress of
a disease might be modeled as healthy, sick and dead instead of healthy and dead,
where the competing nature of death and disease has to be taken into account. Also,
individual characteristics can vary significantly between observational units, like
patients, resulting in idiosyncratic hazard rates and different disease trajectories.
These considerations require flexible modeling assumptions. Current standard
models, however, are often ill-suited for such an analysis. To overcome these
issues, we propose the use of neural ordinary differential equations as a flexible
and general method for estimating multi-state survival models by directly solving
the Kolmogorov forward equations. To quantify the uncertainty in the resulting
individual cause-specific hazard rates, we further introduce a variational latent
variable model. We show that our model exhibits state-of-the-art performance on
popular survival data sets and demonstrate its efficacy in a multi-state setting.
1 Introduction
Time-to-event analysis is of fundamental importance in many fields where there is interest in the time
until the occurrence of particular events, while allowing for time-dependent missing outcomes (i.e.
“censored” data). Examples include time-to-death analysis in medicine [46], failure of mechanical
systems in engineering [42] and financial risk [12]. If the events are additionally fatal, we speak of
survival analysis. For simplicity most survival models only consider the binary case where one is
interested in the transition from one non-fatal to a fatal state. The aim of many such models is to
relate the arrival of events with observed characteristic information, e.g. model a patient’s survival
probability given a set of individual covariates. To this date, the standard tool for survival analysis
is the proportional hazards model, introduced in the seminal paper by Cox [10], which assumes a
proportionality between the hazards for different values of the covariates of the model.
A first generalization of standard survival analysis considers multiple competing events, where all
possible state transitions are fatal. For example, in the medical setting a patient can have multiple
causes of death. For the incidence of these separate events, treating the other events as censored
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however leads to a bias due to misspecification of the at-risk population [17] and the competing
nature of the events has to be specifically modeled.
In recent years, with growing data availability and the advent of precision medicine, there has been an
increasing interest in a more refined modeling approach in clinical applications, taking into account
multiple non-fatal states and more complicated relationships between all states [41, 18, 21, 13, 37,
34]. For example, in the case of acute myeloid leukemia individualized genetic prediction based
on a more complicated multi-stage model was used to tailor personalized treatment within first
complete remission [18]. In general, knowing which transitions and end-points are most likely to
occur enhances the clinician’s ability for decision making.
The inclusion of covariates in common approaches for multi-state models usually requires making
strong assumptions regarding the stochastic process and the dependence between model parameters
and covariates. We propose a general alternative approach, based on modeling the Kolomogorov
forward equation of the underlying process using neural ordinary differential equations [9]. The use of
neural networks provides considerably more model flexibility in comparison to previous approaches
allowing the learning of expressive covariate relationships without placing any restrictive modeling
assumption on the states. A state augmentation akin to a memory process further enables us to move
beyond the common Markov assumption in the state transition probabilities. The method presented in
this paper is to the knowledge of the authors the first neural network approach designed to explicitly
handle multi-state survival models without using simplifying assumptions.
2 Background and related work
2.1 Survival analysis
Survival analysis is one of the simplest approaches for the study of time-to-event data. It categorizes
the underlying states of interest as a dichotomous pair of a non-fatal and a fatal event, e.g. alive/dead
for patients or functioning/failure for mechanical devices. In those models interest lies in the transition
from the non-fatal to the fatal (absorbing) state. Let τ denote a random variable describing the time
of the arrival of the fatal event. τ can be flexibly modeled as the first jump of an inhomogenous
Poisson process with density function
f(t | λ) = λ(t)S(t),
where λ denotes the hazard function and S(t) = exp
( − ∫ t
0
λ(s)ds
)
is the survival function. In
many cases, e.g. for patient data in clinical trials or for observational data, some of the participants
will drop out at an earlier stage than the time of conclusion of the study. This gives an ambiguous
meaning to the observed time points, t, which is a fatal-event if there is no censoring (δ = 1) or a
drop-out (δ = 0). In the latter case the only information available is that τ > t which has probability
P(τ > t) = S(t). This is a case of right-censoring. Assuming independence of the censoring process
the likelihood contribution of an individual i is
Li = λ(ti)δiS(ti). (1)
The most widely used tool to obtain the influence of covariates on the survival function S(t) is the
Cox proportional hazards model. This method is a semi-parametric method for the hazard function
λ(t), which is modeled as λ(t) = λ0(t) exp
(
βTx
)
, where β are coefficients for the covariates x
and λ0(t) is a baseline hazard directly estimated from the data. Both the linear nature of the model as
well as the proportional hazards assumption are often violated in practice.
Many extensions of the Cox proportional hazards model have been proposed, aiming to relax one
or both of those assumptions. This includes models using the Cox model structure, but extending it
to non-linear features or non-proportional hazards, e.g. by modeling λ(t) = λ0(t) exp (fθ(x)) with
fθ(x) being a deep neural network, or λ(t) = λ0(t) exp (fθ(x, t)) (continuous time models) [28,
32]; approaches using MLPs [33] or recurrent neural networks [19, 40] for every time step (discrete
time models); Gaussian Process models [2, 16] or generative adversarial networks (GANs) [7].
2.2 A progressive three-state survival model
The aim of multi-state models is a more granular analysis of time-to-event phenomena, where
common binary outcomes (i.e. health/death) can not adequately describe real observations. A simple
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1 Health
2 Cause A
3 Cause B
λ12(t
)
λ13(t)
(a) Competing hazards model.
1 Health
2 Illness
3 Death
λ12(t
)
λ13(t)
λ23(t)
(b) General multi-state model.
Figure 1: Example graphs corresponding to the 2-state competing hazards model (a) and the illness-
death model (b), a popular multi-state model. Competing hazard models are a special case of
multi-state models that only have one non-absorbing state, whereas in general multi-state models can
have arbitrary, even cyclical connections.
extension of a traditional binary survival model observing the time to a fatal event is the addition of
an intermediate state, illness, which could denote the appearance of symptoms or, more generally,
some non-fatal disease progression. Such models and their state-space can be described by a directed
graph as shown in Figure 1b. For processes that are assumed to evolve continuously over time where
observational units, like patients, move between states this suggests models using continuous time,
finite state space Markov processes. The Markov process is completely characterized by the state
transition probabilities for all tuples of states (i, j) and all tuples of time points (s, t)
Pij(s, t) = P(Y (t) = j | Y (s) = i),
where Y (s) denotes the state of an individual at time s.
Describing the transition probabilities, and hence the likelihood, with a model that allows for flexible
use of covariates, while allowing non-homogeneous state evolution is challenging. The standard tool
is a Markov multi-state model, where a Cox proportional hazards model is applied to each transition
separately. The transition probabilities are then given by assuming a Markov model for the transition
through states [47]. This has the obvious disadvantages of the Cox proportional hazard model at each
transition and additionally a Markov assumption for each state, together with the assumption that
event times for different events are independent of each other, which is rarely given in practice. In the
case of partially observed progressive models there have been extensions to hidden Markov models
[26] and attentive state space models [3], with hidden, unsupervised state evolution. While these
models are extremely interesting in their own right, they aim to solve a somewhat different problem.
However, an application of our approach to model the hidden state dynamics for continuous time
processes would be an interesting avenue for further research.
The conceptually more appealing approach of solving the Kolmogorov forward equation was intro-
duced in [44]. However, the proposed B-spline basis for the hazard function does not generalize
well to inclusion of covariates, as a separate Kolmogorov forward equation has to be fit for every
realization of the covariates. Recently, generalizations to the special case of competing hazard models
using Gaussian Processes [2] and deep neural networks [33] were proposed, however we are not
aware of any literature considering an extension of such flexible methods to the setting of general
multi-state models.
3 Multi-state survival models
Mathematically, we define a continuous time stochastic process {Y (t); 0 6 t 6 T} taking values in
a finite state space Y = {1, ..., S} over known time horizon T > 0. Such processes are often called
(Markov) jump processes. In the following we will describe the likelihood function and its relation to
the Kolmogorov forward equations [30, 15].
3.1 Multi-state likelihood and Kolmogorov equations
For each individual we will observe the process Y (t) in the form of discrete jumps over the relevant
time interval [0, T ].
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In this setting, a single observations consists of a set of m time-indexed states y(t1), . . . , y(tm). The
likelihood is given by
P (y(t1), . . . , y(tm); θ) = P (y(t1))
∏m
j=2
Py(tj−1)y(tj−1) (tj−1, tj ; θ)λy(tj−1)y(tj)(tj | θ),
where θ denotes all free model parameters and P (y(t1)) the probability to be in the initial state. To
avoid confusion, we define
∏1
j=2 = 1. The full likelihood for a set of n observations is thus given by
L(θ;Y) =
∏n
i=1
P
(
yi(t
i
1), . . . , yi(t
i
mi); θ
)
,
with Y = {y1, . . . , yn}, yi = {yi(ti1), . . . , yi(timi)}, i = 1, . . . , n. Under the Markov assumption
the evolution of the transition probabilities in the likelihood is governed by the Kolmogorov forward
equation
dPij(s, t)
dt
=
∑
k
Pik(s, t)λkj(t), i = 1, . . . , S, j = 1, . . . S, (2)
where the Markov property is evident by the fact that the instantaneous transition rates λij(t) are
only dependent on the time t.
3.2 Right-censoring
As alluded to earlier, censoring is common in survival models and requires an adjustment of the
likelihood function. Assuming independence of the censoring process, we observe {xi, yi, δi; j =
1, . . . ,mi, i = 1, . . . , n}, where xi are individual covariates or regressors, mi is the number of
transitions the individual i is going through and yi are as above or the state at time of last contact
(censoring time). Censoring is indicated by δi = 0 whereas we write δi = 1 if the event is observed.
The corresponding likelihood can then be written as
L(θ;Y) =
∏n
i=1
P
(
yi(t
i
1)
)∏mi−1
j=2
Pyi(tij−1)yi(tij−1)
(
tij−1, t
i
j ; θ
)
λyi(tij−1)yi(tij)(t
i
j | θ)
× Pyi(timi−1)yi(timi−1)
(
timi−1, t
i
mi ; θ
) (
λyi(timi−1)yi(t
i
mi
)(t
i
mi | θ)
)δi
.
Remark (Left- and interval-censoring). Left-censoring, where the participants are unobserved at the
beginning or interval censoring which is a combination of left- and right-censoring can be dealt with
similarly, see e.g. Van Den Hout [45] therefore enabling the modeling of partially observed Markov
processes.
We note that the above likelihood already includes possible left-truncation, where a patient is added
at a later time, but known to be in a certain state up until this point, for example to control for
immortal time bias.
4 SURVNODE: neural ODEs for multi-state modelling
We model the instantaneous transition rate matrix Q(t) with a neural network. Conservation of
probability means the elements (Q)ik = λik of the transition rate matrixQ need to fulfill∑
k
λik(t) = 0.
This restriction can be implemented by modelling λij(t), i 6= j through the neural network and set
λii(t) = −
∑
k 6=i λik(t). As we need the transition rates to be larger than 0, we use a softplus
activation on the last layer of the network.
To incorporate the covariates we use the following approach. Instead of only modeling the Markovian
transition rateQ(t), we incorporate the history of the evolution and the covariate state of individual
i as Q(t,H(t)). For this we introduce auxiliary memory states m(t), governed by the differential
equation
dmi
dt
=Mi(t,P (t),m(t)).
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The initial conditions are encoded by the covariates of the patient m(0) = f(x), where f is given by
a neural net. We can then obtain the system of coupled ODEs
dPij(0, t)
dt
=
∑
k
Pik(0, t)λkj(t,P (0, t)(t),m(t))
dPij(s, 0)
ds
= −
∑
k
λik(s,P (0, s),m(s))Pkj(s, 0)
dmi
dt
=Mi(t,P (t),m(t)).
where the second line is the Kolmogorov backward equation. Using that P (s, 0) = P−1(0, s) and
therefore
∑
k Pik(s, 0)Pkj(0, t) = Pij(s, t), we obtain Pij(s, t) at any s and t.
We model both λij(t,P (0, t),m(t)) and Mi(t,P (0, t),m(t)) with one neural network
g(t,P (0, t),m(t)), where the first q (number of non-zero off-diagonal elements of Q) outputs
of the last layer are passed through a softplus non-linearity. The neural network g can also
explicitly depend on the covariates x, however we did not find this to improve the results. This
generalizes the approach in [9] and shares some conceptual ideas with [27]. Another interpretation of
the memory states is the augmentation of the neural ODE with additional states as seen in [14]. The
algorithm is shown in Algorithm 1.
Algorithm 1 Obtain Pij(s, t) and λij(t) in SURVNODE
Input: Covariates x, time interval (s, t).
m(0) = fθ(x), P (0, 0) = 1→ s0 = (P (0, 0),P (0, 0),m(0)) . Get initial values.
def KFE_KBE(P (0, t),P (t, 0),m(t), t): . Kolmogorov forward and backward equation.
λij(t), Mi(t) = gφ(P (0, t),m(t), t) . λ, M from NN with softplus for λ.
λii = −
∑
k λik . Enforce constraints.
dPij(0,t)
dt =
∑
k Pik(0, t)λkj . Calculate gradient for Kolmogorov forward equation.
dPij(t,0)
dt = −
∑
k λikPkj(t, 0) . Calculate gradient for Kolmogorov backward equation.
dmi(t)
dt =Mi(t) . Calculate gradient for augmented evolution.
return
[
dPij(0,t)
dt ,
dPij(t,0)
dt ,
dmi(t)
dt
]
. return derivatives
P (0, t),P (s, 0),m(t), · · · = ODEsolve(s0,KFE_KBE, (0, t),save_at = {s, t})
λij(t) = gφ(P (0, t),m(t), t) . Get the instantaneous transition rate.
P (s, t) = P (s, 0) · P (0, t) . Use the composability to get P (s, t)
return Pij(s, t), λij(t)
Following [35], we furthermore add an L2 loss term for the time evolved memory states at the
maximum time of the training batch, which can be seen as some modification of minimizing a
Lyapunov exponent such that comparable initial values produce comparable survival.
With this model we also have direct access to the hazard rate over time. By predicting the hazard rates
for the possible realizations of e.g. a binary feature over time and taking the ratio, we can therefore
get a personalized predictive score for the influence of that feature on the transition rates between
states, which is important for example for predicting treatments or identifying biomarkers in a clinical
setting.
Due to the encoding of the covariates into the initial values of the memory states this model can
naturally extend to include features based on longitudinal data, text data or imaging data by encoding
the initial values with recurrent neural network layers, natural language processing layers or convolu-
tional layers and training those at the same time. The model is implemented in PyTorch [38] using
the torchdiffeq [9] package.
5 Variational SURVNODE: modeling uncertainty
To obtain a quantification of model uncertainty, we further extend the model to a variational setting
by introducing latent variables. Instead of maximum likelihood estimation, the objective will be the
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Table 1: Benchmark of SURVNODE. The results for the other models are taken from [32]. Note that
the results of competing methods are more hyperparameter optimized.
Model METABRIC METABRIC METABRIC SUPPORT SUPPORT SUPPORT
c ibs ibll c ibs ibll
Cox-PH[10] 0.628 0.183 -0.538 0.598 0.217 -0.623
DeepSurv [28] 0.636 0.176 -0.532 0.611 0.214 -0.619
Cox-Time [32] 0.662 0.172 -0.515 0.629 0.212 -0.613
DeepHit [33] 0.675 0.184 -0.539 0.642 0.223 -0.637
RSF [24] 0.649 0.175 -0.515 0.634 0.212 -0.610
SURVNODE 0.667 0.157 -0.477 0.622 0.198 -0.580
variational free energy or evidence lower bound ELBO. The variational model assumes the existence
of a latent state z, which replaces the role of the memory statem(0) above, such that L(θ;Y, z) does
not depend on the covariates x given z. The objective is then
ELBO(θ,Y) = Eq(z|t,x)
[
logL(θ;Y, z)]−DKL(q(z | t,x) ‖ p(z | x))
where we model the variational distribution q(z|t,x) and the prior p(z|x) as
q(z|t,x) = N (µq(x, t), diag(σ2q (x, t)))
p(z|x) = N (µp(x), diag(σ2p(x)))
with neural networks for µq , µp, σq , and σp, encoding the covariates into the latent space.
For prediction, we obtain realizations of the transition matrix Pij(0, t) by repeated sampling from the
prior and taking the mean as well as the 95% credible interval
z(0) ∼ p(z | x), Pij(0, t | z) = ODEsolve((1,1, z(0)),KFE_KBE, (0, t))
with the ODEsolve term specified in Algorithm 1.
6 Experiments
6.1 Survival: benchmark of model
To benchmark our proposed model against various survival frameworks, we examine the performance
of SURVNODE on the METABRIC breast cancer data set [11, 39], as well as the SUPPORT data set [29].
We present the benchmark concordance (c)[4], integrated Brier score (ibs)[6] (which is an estimation
of the deviation from true probability) as well as the integrated binomial log-likelihood estimator
(ibll) with five-fold cross validation in Table 1.
While the concordance solely evaluates a method’s discriminative performance, the Brier score and
binomial log-likelihood also evaluate the calibration of the survival estimates. In the example of a
diagnostic test in a clinical setting a low integrated Brier score corresponds to a better predictive
value of the diagnosis, meaning the probabilities of a positive or negative diagnosis are closer
to the real underlying probabilities. A higher concordance, on the other hand, will give a better
classification into positive diagnosis or negative diagnosis [20]. As can be seen in Table 1, our
method outperforms all competitors in terms of calibration (ibs, ibll) while attaining state-of-the-
art discriminative performance as measured by the concordance index. An illustration of this is
shown in the supplemental material. Although concordance is a common figure of merit, for clinical
applications of predictive models for precision medicine, it is arguably more important to have a well
calibrated probability for the event to provide the clinician with unbiased decision support [20, 22,
25].
6.2 Multi-state survival: competing hazards and the illness death model
To show the efficacy of our model in the multi-state setting we first turn to the simplest extension of
survival models, the competing hazards model (Figure 1a). In this setting all possible states the model
can transition to are absorbing, and hence there are no intermediate states. In this specific multi-state
6
Table 2: Benchmark in the competing hazards case with five-fold cross validation.
Model concordance cause 1 concordance cause 2
Cause-specific Cox model [10] 0.578± 0.004 0.588± 0.002
Fine-Gray [28] 0.579± 0.004 0.589± 0.008
DeepHit [33] 0.739± 0.002 0.737± 0.003
DeepHit (with ranking loss) [33] 0.755± 0.003 0.755± 0.004
SURVNODE (this paper) 0.736± 0.006 0.739± 0.007
0 50 100 150 200 250
t
0.0
0.2
0.4
0.6
0.8
1.0
P(
X(
t)=
k) SurvNODE
Multistate Cox
Aalen-Johansen Estimator
(a) SURVNODE
0 50 100 150 200
t
0.0
0.2
0.4
0.6
0.8
1.0
P(
X(
t)=
k) SurvNODE
Multistate Cox
Aalen-Johansen Estimator
(b) Variational SURVNODE
Figure 2: Plot of probabilities for being in the different states of the illness-death model, indicated by
the different colors. Blue corresponds to “Health”, red to “Illness” and green to “Death”. We compare
to the cause-specific multi-state Cox model in addition to the non-parametric Aalen–Johansen
estimator of the test data.
case we can benchmark our model against the standard tools for competing hazards analysis: The
cause-specific Cox models, where a Cox proportional hazards model is fit for each transition taking
all other transitions as censored; the Fine–Gray model [17]; as well as DeepHit [33] and DeepHit
with an additional loss term to specifically improve concordance, at the cost of worse calibration [32].
We benchmark on the SYNTHETIC data set provided by [33] with two possible competing outcomes.
Our results for cause-specific concordance are compared with those from [33] in Table 2.
We note that we use an ad-hoc hyperparameter setting and do not perform hyperparameter tuning
using the validation set, in contrast to the analyses in [33]. Nevertheless, our model outperforms the
conventional Cox models and is competitive with DeepHit without the ranking loss, thus demonstrat-
ing the robustness of our method.
To visualize the advantage of our model over the standard tools in the multi-state setting, we seek to
compare with a non-parametric estimator for an illness-death model (Figure 1b). In the multi-state
setting a population mean for the probabilities in each state can be obtained with the Aalen–Johansen
estimator [1]. We simulate a data set with proportional hazards violation using the coxed R package
[23](see supplementary material). We compare our model with the standard tool in the multi-state
survival literature, which is fitting a Cox proportional hazard model to each transition, treating the
other events as censored. Importantly, this assumes independence between the occurring events,
which while true for the simulated data set is often not the case in real world scenarios. We use the
R package mstate [47] to get the state probabilities at each time. The comparison can be seen in
Figure 2a and we see a clear advantage of our model over the cause-specific Cox model.
6.3 Latent multi state survival model
Benchmark As a first step of analysis of the latent multi-state survival model, we benchmark
the model against other models for the special case of survival analysis on the METABRIC data
set. Without any hyper-parameter tuning and ad-hoc parameter choice, we obtain a concordance
of c = 0.646, integrated Brier score of 0.170 and integrated binomial log-likelihood of 0.503. As
such the variational SURVNODE is better calibrated than all other available models with competitive
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Table 3: Comparison of SURVNODEand the Cox proportional hazard model in terms of calibration
and concordance.
Model calibration concordance
Cox proportional hazards model [10] 0.250± 0.015 0.6244± 0.0064
SURVNODE (this paper) 0.749± 0.071 0.6396± 0.0097
5 0 5 10
UMAP1
5
0
5
10
UM
AP
2
Cluster 1
Cluster 2
Cluster 3
Cluster 4
Cluster 5
0.0
0.5
1.0
P(
X(
t)=
1)
Cluster 1
Cluster 2
Cluster 3
Cluster 4
Cluster 5
0.0
0.5
P(
X(
t)=
2)
0.0 0.1 0.2 0.3 0.4 0.5
t
0.0
0.5
1.0
P(
X(
t)=
3)
Figure 3: The latent space of the variational SURVNODE model exhibits unsupervised clustering into
meaningful clusters. The subset of patients in the clusters on the left are used in a non-parametric
Aalen–Johansen estimator to show clear significant differences in the probabilities of the different
states depending on the cluster. State 1 is hereby the initial "Health" state, 2 corresponds to "Illness"
and 3 to the absorbing "Death" state.
discrimination performance (not including plain SURVNODE). We can visualize the prediction and
confidence interval by again comparing to the Aalen–Johansen estimator in the simulated illness-
death model in Figure 2b. For this we have trained the variational SURVNODE on a training set with
early stopping on a validation set and compare the prediction for the possible covariates with the
Aalen–Johansen estimators obtained on a test set.
Calibration of the credible intervals While our model captures the non-parametric estimator by
visual inspection, we seek to quantify the calibration performance. Again using the R package
coxed, we simulate a survival data set with three covariates. From the coxed package we also
extract the underlying individual survival probabilities. To estimate calibration of the error intervals,
we therefore calculate the average of fraction of times the true survival probabilities we sample from
lie within the 95% credible interval. We compare the calibration of our model to the prediction
from a Cox proportional hazards model using the R survival package [43], which implements the
calculation of standard errors. For one random realization of the simulated data we perform a five
fold cross validation in Table 3. We find our model to be more conservative for the error intervals and
to be better calibrated.
Clustering of the latent space On top of the estimation of credible intervals, an additional useful
feature of the latent variable model can be found by inspection of the latent space of the model. We
again simulate an illness-death model data-set with coxed, using three covariates, which we bin into
three quantiles each. We again run the variational SURVNODE model with early stopping using a
validation set and then inspect the latent space for the validation data. Using UMAP [36] we identify
five clusters (Figure 3). We examine the probabilities to be in each of the "Health", "Illness" and
"Death" states for each cluster in the validation data set using the non-parametric Aalen–Johansen
estimator. As can be seen in Figure 3, the clusters are a meaningful unsupervised differentiation
between patients and capture survival differences as well as differences in transitioning to the "Illness"
state well. We can additionally obtain covariate effects associated with each cluster by using logistic
regression. This feature has useful applications in a clinical setting, where identification of extreme
survivors to a treatment while modeling other state transitions is of particular interest.
Our approach is directly applicable to survival analysis, where methods for example based on LDA
[8] were recently proposed to cluster the latent space, but generalizes those to the multi-state setting.
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7 Conclusion
We have introduced a general and flexible method for multi-state survival analysis based on neural
ODEs and shown state-of-the art performance in the special cases of survival and competing risk
analysis. We can get an estimation of credible intervals for the model as well as an interpretability
aspect by introducing latent states.
Broader Impact
We were motivated by the explicit desire to solve a problem in the field of cancer immunotherapy,
where treatment outcomes are highly heterogeneous and the proportional hazard assumption is often
violated [5]. We are interested in multi-state modeling to predict the onset of immune related adverse
events in competition with mortality, survival after developing adverse events, and decision support
for further re-challenge with immunotherapy. It is our hope that the prediction aspect of the model
presented here can be used to support clinical decision making by anticipating potential interventions
prior to the onset of harm. Reliable modeling of uncertainty in the prediction is thus crucial for this
practical application. We further plan to use the latent space clustering, in conjunction with biological
covariates, for sub-phenotyping, and biomarker discovery for adverse events. We believe our model
is broadly applicable in clinical settings with dynamic events and latent sub-populations, and hope to
have a meaningful impact on AI-based precision medicine.
Clinical decision support also comes with risk, as model failure can be hazardous for the patient
either by ending a successful treatment needlessly early, or by continuing a treatment when it has
failed and leads to harmful side effects. Actions based on model predictions must thus consider
uncertainty in the prediction itself as well as the broader harm/benefit trade-offs. In the specific case
of immunotherapy-related adverse events, interventions such as increased patient monitoring/contact
may pose limited risk for harm. However, much uncertainty remains over the ethical use of survival
prediction, as immunotherapy offers the potential of permanent elimination of disease (in contrast to
many treatments of advanced cancers), patients may be more inclined to continue treatment against
the guidance of a predictive model, in the hopes of a cure.
As with any statistical method, the output relies on the quality of the underlying data, e.g. electronic
health records (EHR). Due to systemic biases there is often a difference in the availability and accuracy
of EHR between different communities, and special care has to be taken that computational models
are not themselves biased by data quality, and thus further exacerbating existing disparities. The
algorithm may exploit biases in the data leading to decisions that would be considered discriminatory
behavior by a human counterpart. Identifying such biases necessitates model interpretability through
clustering and feature importance [31], as well as assessment in diverse populations.
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Supplementary Material: Neural ODEs for Multi-State Survival Analysis
A Implementation details
All models are implemented in PyTorch v1.4 [9] using the torchdiffeq package [2]. As our
example networks are sufficiently small, we use backpropagation through the ODE solver to obtain
gradients, however, using the adjoint method is possible. We use the dopri5 method for the ODE
solver with an absolute and relative tolerance of 10−7 in the ODE solver. To include the accuracy of
the solution as a hyperparameter, we scale the event times to have the maximum value S, which we
choose to be of O(1). To specify the non-zero elements of the transition rate matrix, a matrix with 1
indicators for non-zero off-diagonal elements and NaN indicators for all other elements are needed.
For training the model minimizing the negative log likelihood, the hyperparameters are:
• Number of layers Le and number of neurons per layer Ne with dropout[12] pe for multilayer
perceptron encoding the covariates into memory states;
• Number of layers LQ and number of neurons per layer NQ for multilayer perceptron
modelingQ;
• Number of memory states M ;
• Coefficient of Lyapunov style loss term µ;
• Scaling coefficient for event times S;
• Learning rate l of the Adam optimizer [6];
• Weight decay w.
For the variational approach minimizing the ELBO, we have the hyperparameters:
• Number of layers Lp and number of neurons per layer Np with dropout pp for multilayer
perceptron for prior p(z|x);
• Number of layers Lq and number of neurons per layer Nq with dropout pp for multilayer
perceptron for variational postierior q(z|x, t);
• Number of layers LQ and number of neurons per layer NQ for multilayer perceptron
modelingQ;
• Number of latent states M ;
• Coefficient of Lyapunov style loss term µ;
• ELBO parameter β
• Scaling coefficient for event times S;
• Learning rate l of the Adam optimizer;
• Weight decay w,
where the ELBO parameter β characterizes the relative weight between log likelihood and Kullback-
Leibler divergence, which we set to be 1 throughout the paper. Closer investigation of the clustering
property with respect to this parameter would be of interest.
Due to the implementation of the algorithm, solving the Kolmogorov backward equation at the same
time as the Kolmogorov forward equation, we only need to solve the ODE once per batch from 0 to
max(tBATCH) to get Pij(s, t) for all patients in the batch, as we can store the solution at the union of
all s and t and then compute
Pij(s, t) =
∑
k
Pik(s, 0)Pkj(0, t).
We note that due to the implementation of the differential equation solver in native python code,
the computational speed of the method could be increased. As shown in benchmarks [10], the julia
programming language [1] and the DiffEqFlux [11] package might offer a great alternative and we
are currently working on a julia implementation.
B Experiments
B.1 Simulation of data
The simulated data in the publication is generated with the R package coxed. In the survival cases,
we choose three covariates, where one of the covariates has time varying coefficients to model a
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Table 4: Characteristics of the METABRIC and SUPPORT data sets.
Data set Size Covariates Unique Durations Prop. Censored
SUPPORT 8873 14 1714 0.32
METABRIC 1904 9 1686 0.42
proportional hazards violation. We choose all coefficients to be of O(1), with a saw-tooth time
dependence for the time dependent covariate. We sample 2048 patients for the training set and 1024
patients for the validation and test set respectively with event times between 0 and 100.
In the case of the illness death model, we sample using the coxed package for every transition,
assuming independence of each transition. We extract the covariates from the first sampled model
and use them for the other two survival realizations, however choosing different coefficients. Due to
a limitation of the coxed package, only the first sampled model can have time varying coefficients,
with the other transitions then effectively being sampled from a Cox-model. In the competing case
between "Illness" and "Death" from the "Health" state, we choose the first ocurring time of the two
sampled survival data realizations, no matter if there is censoring or not. The maximum time for the
generated data in the competing case is T = 100, whereas we choose T = 50 for the transition from
"Illness" to "Death".
B.2 Data sets and hyperparameters
The METABRIC and SUPPORT data sets are standard survival data sets for benchmarking. The
characteristics are shown in Table 4 [7] and are obtained from the pycox python package [7]. The
SYNTHETIC data set in the competing hazards case is taken from [8] and available on github with
30000 patients and two outcomes, where 50% of patients experience any event, whereas the other
50% are censored.
For all benchmark experiments we do a five-fold cross validation where we split the data in an 80−20
split into 20% test-data and the remaining data again in an 80− 20 split into 64% training data and
16% validation data.
The hyperparameter space used in the benchmarks on METABRIC and SUPPORT are
• Le = 2 with Ne = [400, 1000] and pe = 0.1;
• Lq = [2, 4] with Nq = [400, 1000]
• M = [50, 150];
• µ = 10−4;
• S = 2.;
• l = [1e− 4, 1e− 3];
• w = [1e− 7, 1e− 3].
We use random sampling from the hyperparameter space to get 16 realizations of the hyperparameters.
The batch size is taken to be either 512 or the length of the data set, whichever is smaller.
For the competing hazards experiment we use the hyperparameters
• Le = 2 with Ne = 400 and pe = 0.1;
• LQ = 2 with NQ = 1000
• M = 30;
• µ = 10−4;
• S = 1.;
• l = 1e− 4;
• w = 1e− 7.
For the comparison with the non-parametric Aalen Johansen estimator the hyperparameters used for
the model minimizing the negative log likelihood were
• Le = 2 with Ne = 800 and pe = 0.;
• LQ = 3 with NQ = 1000
• M = 20;
• µ = 10−4;
• S = 1.;
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• l = 1e− 4;
• w = 1e− 7.
In the case of the latent model minimizing the ELBO we used
• Lp = 2 with Np = 400 and pp = 0.;
• Lq = 2 with Np = 1000 and pp = 0.;
• LQ = 3 with NQ = 1000
• M = 70;
• µ = 10−4;
• S = 1.;
• l = 1e− 4;
• w = 1e− 7;
• β = 1,
and finally for clustering the latent space the hyperparameter setting we use is
• Lp = 2 with Np = 400 and pp = 0.;
• Lq = 2 with Np = 400 and pp = 0.;
• LQ = 2 with NQ = 1000
• M = 50;
• µ = 10−4;
• S = 1.;
• l = 5e− 5;
• w = 1e− 7;
• β = 1.
C Visualisation of calibration in the survival setting
We can examine the calibration of the model in the simple case of one binary covariate. In this case
we can use the population level non-parametric Kaplan–Meier estimator [5] to obtain the survival
function S(t). We use the R package coxed [4] to simulate survival data with proportional hazards
violation and one binary variable var. We split the data set into training, validation and test set
and obtain the Kaplan–Meier estimator for both variable var = 0 and var = 1 on the test data.
The survival model is trained on the training data with early stopping using the validation data and
predicted for var = 0 and var = 1. This prediction is compared to the Kaplan–Meier estimator on
the test data. We compare our model (SURVNODE) with a Cox proportional hazards model, a fully
parametric accelerated failure time model based on the Weibull distribution [3], as well as DeepHit
[8] and Cox-Time [7], a discrete and continuous time machine learning model, respectively. The
visual comparison can be seen in Figure 4. We see that due to the proportional hazard violation, the
Cox model as well as the model based on the parametric Weibull distribution do not capture the
survival function well, whereas the SurvNODE model does. Comparing to the other machine learning
based frameworks, we see that DeepHit does not reproduce the survival function well.
D Clustering: Covariates and survival strata
To further examine the clustering of the latent space, we can superimpose the nine binary covariates
in the model on the UMAP projection. This can be seen in Figure 5. We see that some of the clusters
clearly reflect the covariates, for example in the case of covariate one, which is the lowest third of the
covariate with the largest effect size for one of the transitions in the simulation, we see that almost all
the values are in one of the clusters. By characterizing the effect of the covariates on these clusters
with specific survival properties, we can obtain the influence of the covariate on survival.
E Calibration of the credible intervals
A visual way to show the calibration of the credible intervals is to predict individual survival over
time and plot together with the true underlying survival function obtained from the coxed R package.
This can be seen in Figure 6. We see that the credible intervals contain the survival function in most
of the cases.
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Figure 4: Comparison of different tools to fit survival distributions in the population level case of one
binary covariate. On the left our model is compared with the standard tools of survival analysis and
the non-parametric Kaplan–Meier estimator of the test set. On the right we compare our model on
the same data with two state of the art machine learning approaches, again with the Kaplan–Meier as
a non-parametric estimator.
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Figure 5: Possible values of the nine binary covariates in the model. We see that some of the clusters
clearly reflect the covariates.
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